Increased expression of CBX3 is correlated with an unfavorable prognosis in NSCLC and LUAD [50,51] through mechanisms involving the promotion of tumor proliferation via regulatory pathways of signal transduction affecting the cell cycle, notably G1/S phase transition and the p53 pathway [10]. This evidence concerns the gene CBX3 and neoplasm.